Trial Profile
Golimumab Rescue for Active Crohn's Disease Refractory to Other Therapies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2015
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 16 Sep 2015 New trial record